Equillium Inc (EQ)
1.57
+0.03
(+1.95%)
USD |
NASDAQ |
May 17, 16:00
1.57
0.00 (0.00%)
After-Hours: 20:00
Equillium Free Cash Flow (Quarterly): -8.819M for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -8.819M |
| December 31, 2023 | -5.699M |
| September 30, 2023 | -1.924M |
| June 30, 2023 | -6.215M |
| March 31, 2023 | -7.995M |
| December 31, 2022 | 27.72M |
| September 30, 2022 | -13.06M |
| June 30, 2022 | -11.31M |
| March 31, 2022 | -12.36M |
| December 31, 2021 | -10.13M |
| September 30, 2021 | -7.044M |
| June 30, 2021 | -7.017M |
| March 31, 2021 | -7.944M |
| Date | Value |
|---|---|
| December 31, 2020 | -8.283M |
| September 30, 2020 | -5.078M |
| June 30, 2020 | -5.08M |
| March 31, 2020 | -6.385M |
| December 31, 2019 | -9.051M |
| September 30, 2019 | -4.696M |
| June 30, 2019 | -4.801M |
| March 31, 2019 | -4.475M |
| December 31, 2018 | -3.836M |
| September 30, 2018 | -1.645M |
| June 30, 2018 | -1.186M |
| March 31, 2018 | -0.894M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-13.06M
Minimum
Sep 2022
27.72M
Maximum
Dec 2022
-5.759M
Average
-7.030M
Median
Free Cash Flow (Quarterly) Benchmarks
| Janux Therapeutics Inc | -15.03M |
| Mersana Therapeutics Inc | -32.79M |
| Vera Therapeutics Inc | -33.83M |
| NovaBay Pharmaceuticals Inc | -1.574M |
| Palatin Technologies Inc | -8.607M |